Skip to content

Drug manufacturers: value-based arrangement.

This bill did not become law and its session has ended, so it can no longer move. It would have to be reintroduced.

CA SB 521 · Senate Bill · 2021–2022

Stage
Session ended
Started in
Senate
Sponsor
1
Latest action
Aug 26, 2021

What it does

Existing law establishes the Medi-Cal program, which is administered by the State Department of Health Care Services, under which qualified low-income individuals receive health care services, including prescription drugs that are subject to the Medi-Cal List of Contract Drugs, pursuant to a schedule of benefits. The Medi-Cal program is, in part, governed by, and funded pursuant to, federal Medicaid program provisions.

Read the full text

Where it stands

This bill did not become law and its session has ended, so it can no longer move. It would have to be reintroduced.

  1. Introduced (Done)

  2. Committee (Done)

  3. Floor (Current step)

    Passed first chamber · Aug 26, 2021

  4. Law (Needs attention)

    The session ended first

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

While a bill can still move, the questions are about people and money in California.

Work with this bill

Drug manufacturers: value-based arrangement. | 52